2023 Was a tricky calendar year for the biopharma industry, with various organizations downsizing and restructuring their workforces to stay afloat. You'll find signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and lifestyle sciences business within the latter A part of 2023 and also have ongoing https://sites.google.com/view/bio-sites/blog